Daxor announces duke university study on blood volume analysis in heart failure published in american heart journal

Published research demonstrates the value of bva in meeting key goal of identifying anemia in heart failure patients oak ridge, tn, may 14, 2025 (globe newswire) -- daxor corporation (nasdaq: dxr), daxor corporation, the global leader in blood volume measurement technology, today announces significant new findings from duke university medical center published in the prestigious american heart journal. the research demonstrates how blood volume analysis (bva) enables precise measurement of red blood cell mass (rbcm) and effectively differentiates between true and dilutional anemia in heart failure (hf) patients.
DXR Ratings Summary
DXR Quant Ranking